Phase behavior of the antineoplastic ether lipid 1-O-octadecyl-2-O-methyl-glycero-3-phosphocholine
- 1 June 1994
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1192 (2) , 167-176
- https://doi.org/10.1016/0005-2736(94)90115-5
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Physicochemical behavior of cytotoxic ether lipidsBiochemistry, 1992
- Novel Membrane-Interactive Ether Lipid Analogs That Inhibit Infectious HIV-1 Production and Induce Defective Virus FormationAIDS Research and Human Retroviruses, 1990
- Modulation of chemical carcinogenesis in rats by alkyl lysophospholipidsLipids, 1987
- Neoplastic cell inhibition with new ether lipid analogsLipids, 1987
- Ether lipids and analogs in experimental cancer therapy. A brief review of the munich experienceLipids, 1987
- Clinical phase I pilot study of the alkyl lysophospholipid derivative ET‐18‐OCH3Lipids, 1987
- Tumor Cytotoxicity of Human Macrophages After Incubation With Synthetic Analogues of 2-Lysophosphatidylcholine2JNCI Journal of the National Cancer Institute, 1984
- Synthesis of enzyme-inhibitory phospholipid analogs II. Preparation of chiral 1-acyl-2-acylamido-2-deoxyglycerophosphorycholines from serineTetrahedron Letters, 1981
- The influence of alkyl-lysophospholipids and lysophospholipid-activated macrophages on the development of metastasis of 3-Lewis lung carcinomaPublished by Elsevier ,1980
- Molecular aggregation of the slow reacting hemolytic lysolecithin analog 1-octadecyl-2-benzyl-glycero-3-phosphorylcholine in aqueous solutionChemistry and Physics of Lipids, 1976